Expression of biologically active polypeptides in duckweed

Details for Australian Patent Application No. 2004280228 (hide)

Owner Biolex Therapeutics, Inc.

Inventors Spencer, David; Gasdaska, John; Peele, Charles G.; Dickey, Lynn; Cox, Kevin

Agent Spruson & Ferguson

Pub. Number AU-B-2004280228

PCT Pub. Number WO2005/035768

Priority 10/675,011 30.09.03 US; 10/794,615 05.03.04 US

Filing date 16 April 2004

Wipo publication date 21 April 2005

Acceptance publication date 6 October 2011

International Classifications

C12N 15/82 (2006.01) Mutation or genetic engineering - for plant cells

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

4 May 2006 PCT application entered the National Phase

  PCT publication WO2005/035768 Priority application(s): WO2005/035768

18 September 2008 Alteration of Name

  The name of the applicant has been altered to Biolex Therapeutics, Inc.

6 October 2011 Application Accepted

  Published as AU-B-2004280228

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004280229-Drug-delivery vehicles based on reversed liquid crystalline phase materials

2004280227-Alpha interferon variants